Is oxidant stress a connection between obesity and atherosclerosis?

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 3, 2003, Pages 368-370

  Morrow, Jason D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN; ANTIOXIDANT; FREE RADICAL; ISOPROSTANE DERIVATIVE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIET SUPPLEMENTATION; EDITORIAL; HIGH RISK POPULATION; HUMAN; INFLAMMATION; LIPID PEROXIDATION; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PUBLIC HEALTH; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR;

ANIMALS; ANTIOXIDANTS; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; COMORBIDITY; DIABETES MELLITUS; DISEASE PROGRESSION; F2-ISOPROSTANES; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; OBESITY; OXIDATIVE STRESS; SEX DISTRIBUTION; SMOKING;

EID: 0037339931     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000063107.86298.FD     Document Type: Editorial

References (39)

1. Eckel RH, Barouch WW, Ershow AG. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease. Circulation. 2002;105:2923-2928.
2. National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity and health risk. Arch Int Med. 2000;160:898-904.
3. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med. 1999;341:1097-1105.
4. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003;289:187-193.
5. Grundy SM. Obesity, metabolic syndrome and coronary atherosclerosis. Circulation;. 2002;105:2696-2698.
6. Keaney JF, Larson MG, Vasan RS, Wilson PWF, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ. Obesity and systemic oxidant stress: clinical correlates of oxidative stress in the Framingham Study. Arteroscl Thromb Vasc Biol. 2003;23:434-439.
7. Heineke JW. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis. 1998;141:1-5.
8. Berliner J, Leitinger N, Watson A, Huber J, Fogelman A, Navab M. Oxidized lipids in atherogenesis: formation, destruction and action. Thromb Haemostasis. 1997;78:195-199.
9. Chisholm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med. 2000;18:1815-1826.
10. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis. basic mechanisms: oxidation, inflammation, and genetics. Circulation. 1995;91:2488-2496.
11. Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegl G. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol. 1990;3:77-92.
12. Subbanagounder G, Watson AD, Berliner JA. Role of oxidation in atherosclerosis: bioactive products of phospholipids oxidation: isolation, identification, measurement and activities. Free Radic Biol Med. 2000;28:1751-1761.
13. Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nature Med. 2002;11:1235-1242.
14. Rader DJ. Inflammatory markers of coronary risk. N Engl J Med. 2000;343:1179-1182.
15. Brasier AR, Recinos A, Eledrisi MS. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol. 2002;22:1257-1266.
16. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
17. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
18. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997;337:408-413.
19. Pratico D, Tangirala RK, Rader DJ, Rokach J, FitzGerald GA. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice. Nature Med. 1998;4:1189-1192.
20. Heinecke JW. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis. Arterioscler Thromb Vasc Biol. 2001;21:1261-1264.
21. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers: the Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330:1029-1035.
22. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial - Gruppo Italiano per lo Studio Della Sopravvivenza nell'Infarto Miocardico. Lancet. 1999;354:447-455.
23. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamine E supplementation and cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154-160.
24. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 "high risk" individuals: a randomized placebo-controlled trial. Lancet. 2002;360:23-33.
25. Brown BG, Zhao X-Q, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino ED, Bolson EL, Laupovic P, Frohlich J, Albers JJ. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1583-1592.
26. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-786.
27. Boaz M, Smetana S, Weinstein T, Matas, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomized placebo-controlled trial. Lancet. 200;356:1213-1218.
28. Meagher EA, Barry OP, Lawson JA, Rokach J, FitzGerald GA. Effects of vitamin E on lipid peroxidation in healthy persons. JAMA. 2001;285:1178-1182.
29. Morrow JD, Chen Y, Brame CJ, Yang J, Sanchez SC, Xu J, Zackert WE, Awad JA, Roberts LJ. The isoprostanes: unique prostaglandin like products of free radical-catalyzed lipid peroxidation. Drug Metab Rev. 1999;31:117-139.
30. 2-isoprostanes: a reliable index of oxidant stress in vivo. Free Radic Biol Med. 2000;28:505-513.
31. Roberts LJ, Morrow JD. Isoprostanes as markers of lipid peroxidation in atherosclerosis. In: Serhan CN, Ward PA, eds. Molecular and Cellular Basis of Inflammation. Totowa NJ: Humana Press; 1998:141-163.
32. Voutilainen S, Morrow JD, Roberts LJ, Alfthan G, Alho H, Nyyssonen K, Salonen JT. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol. 1999;19:1263-1266.
33. 2-isoprostanes) are increased in the circulation of smokers: evidence that smoking causes oxidative damage in vivo. N Engl J Med. 1995;332:1198-1203.
34. Block G, Dietrich M, Norkus E, Morrow JD, Hudes M, Caan B, Packer L. Determinants of oxidative stress in human populations. Am J Epidemiol. 2002;156:274-285.
35. Davì G, Guagnano MT, Ciabatton G, Basili S, Falco A, Marinopiccoli M, Nutini M, Sens S, Patrono C. Platelet activation in obese women role of inflammation and oxidant stress. JAMA. 2002;288:2008-2014.
36. Chan JC, Cheung JC, Stehouwer CD, Emeis JJ, Tong PC, Ko GT, Yudkin JS. The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome-an analysis by structural equation modelling. Int J Obes Relat Metab Disord. 2002;26:994-1008.
37. Barton M, Carmona R, Morawietz H, d'Uscio LV, Goettsch W, Hillen H, Haudenschild CC, Krieger JE, Munter K, Lattmann T, Luscher TF, Shaw S. Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. Hypertension. 2000;35:329-336.
38. Trevisan M, Browne R, Ram M, Muti P, Frudenheim J, Carosella AM, Armstrong D. Correlates of markers of oxidative status in the general population. Am J Epidemiol. 2001;154:348-356.
39. Manson JE, Bassuk SS. Obesity in the United States: a fresh look at its high toll. JAMA. 2003;289:229-230.